Article info

Download PDFPDF
Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment
  1. Correspondence to:
    Professor Allan D Struthers
    Department of Clinical Pharmacology and Therapeutics, Ninewells Hospital and Medical School, Dundee DD19SY, UK; a.d.struthersdundee.ac.uk
View Full Text

Citation

Macdonald JE, Kennedy N, Struthers AD
Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment

Publication history

  • Accepted October 27, 2003
  • First published June 14, 2004.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.